Skip to main content

Leonard Frank X

In the past year, 3 open-market sale filings worth $919.7K and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$919.7K
3 filings
Net
−$919.7K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Leonard Frank X as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 5, 2026 (view filing)Jun 41 dayLeonard Frank XChief Executive OfficerSSale−34.3K$17.93−$614.5K−6.9%459.5K after
Mar 5, 2026 (view filing)Mar 41 dayLeonard Frank XChief Executive OfficerSSale−5.61K$13.31−$74.6K−1.1%493.8K after
Mar 3, 2026 (view filing)Feb 27-Mar 24 daysLeonard Frank XChief Executive OfficerSSale−17.0K$13.59−$230.5K−4.6%349.4K after2 lots
Jun 4, 2025 (view filing)Jun 22 daysLeonard Frank XEVP, Pres., Novocure OncologySSale−30.2K$17.50−$528.4K−15.2%168.5K after3 lots10b5-1
Mar 4, 2025 (view filing)Mar 31 dayLeonard Frank XEVP, Pres., Novocure OncologySSale−2.53K$18.54−$46.9K−1.7%143.7K after
Mar 3, 2025 (view filing)Feb 27-284 daysLeonard Frank XEVP, Pres., Novocure OncologySSale−15.0K$19.70−$296.2K−9.3%146.2K afterAmended3 lots
Nov 4, 2024 (view filing)Nov 13 daysLeonard Frank XEVP, Pres., Novocure OncologySSale−598$15.94−$9.53K−0.4%161.2K after
Mar 5, 2024 (view filing)Mar 1-44 daysLeonard Frank XEVP, Pres., Novocure OncologySSale−2.52K$16.02−$40.4K−1.5%160.1K after2 lots
Feb 29, 2024 (view filing)Feb 281 dayLeonard Frank XEVP, Pres., Novocure OncologySSale−2.08K$16.14−$33.5K−1.3%162.6K after
Mar 7, 2023 (view filing)Mar 3-74 daysLeonard Frank XPresident, CNS Cancers USSSale−13.6K$75.55−$1.03M−20.0%54.3K after4 lots
Mar 6, 2023 (view filing)Mar 2-34 daysLeonard Frank XPresident, CNS Cancers USSSale−2.90K$76.95−$223.4K−4.1%67.9K after2 lots
Mar 3, 2023 (view filing)Mar 21 dayLeonard Frank XPresident, CNS Cancers USSSale−4.11K$75.37−$309.6K−6.5%59.0K after2 lots
Mar 2, 2023 (view filing)Mar 11 dayLeonard Frank XPresident, CNS Cancers USSSale−1.68K$76.36−$128.6K−2.6%63.1K after
Jan 9, 2023 (view filing)Jan 54 daysLeonard Frank XPresident, CNS Cancers USSSale−39.5K$112.25−$4.43M−46.1%46.2K after9 lots
Oct 17, 2022 (view filing)Oct 134 daysLeonard Frank XPresident, CNS Cancers USSSale−6.75K$76.01−$513.4K−13.4%43.6K after
Oct 7, 2022 (view filing)Oct 61 dayLeonard Frank XPresident, CNS Cancers USSSale−6.75K$84.37−$569.8K−11.8%50.4K after
Sep 30, 2022 (view filing)Sep 291 dayLeonard Frank XPresident, CNS Cancers USSSale−6.75K$77.35−$522.4K−10.6%57.1K after
Sep 26, 2022 (view filing)Sep 224 daysLeonard Frank XPresident, CNS Cancers USSSale−6.75K$77.00−$520.1K−9.6%63.9K after
Sep 19, 2022 (view filing)Sep 154 daysLeonard Frank XChief Development OfficerSSale−12.3K$88.52−$1.09M−14.8%70.6K after2 lots
Sep 13, 2022 (view filing)Sep 85 daysLeonard Frank XChief Development OfficerSSale−6.75K$81.48−$550.3K−8.0%77.4K afterAmended
Sep 7, 2022 (view filing)Sep 61 dayLeonard Frank XChief Development OfficerSSale−1.38K$78.57−$108.7K−1.6%86.0K after
Sep 6, 2022 (view filing)Sep 1-25 daysLeonard Frank XChief Development OfficerSSale−14.8K$77.50−$1.15M−14.5%87.4K after13 lots
Aug 3, 2022 (view filing)Aug 21 dayLeonard Frank XChief Development OfficerSSale−414$69.66−$28.8K−0.4%102.2K after
Mar 9, 2022 (view filing)Mar 81 dayLeonard Frank XChief Development OfficerSSale−744$70.10−$52.2K−0.7%102.3K after
Mar 7, 2022 (view filing)Mar 3-44 daysLeonard Frank XChief Development OfficerSSale−1.49K$72.97−$108.4K−1.4%103.0K after2 lots
Sep 7, 2021 (view filing)Sep 25 daysLeonard Frank XChief Development OfficerSSale−540$138.23−$74.6K−0.6%87.2K after
Aug 4, 2021 (view filing)Aug 2-32 daysLeonard Frank XChief Development OfficerSSale−1.04K$149.40−$155.5K−1.2%89.2K after2 lots